Search

Having graduated from EPA’s peer review process, the Abt-designed SWEET tool has been updated to better identify and resolve methane emissions.

Substance use disorders (SUDs) involving opioids, fentanyl, and other controlled substances have harmed individuals, families, and communities in every corner of the U.S. Abt Global champions a data-backed, person-centered approach to confronting the global opioid and substance use crisis. Our interdisciplinary teams are dedicated to addressing SUDs and advancing evidence-based approaches for the entire spectrum of care, from prevention to long-term recovery support. Through more than 40 recent projects, we're addressing the opioid epidemic's root causes, evaluating interventions to reduce harm, and supporting improved clinical care. We collaborate with federal agencies, healthcare systems, and community service providers nationwide to evaluate effectiveness, enhance chronic pain care, and support the implementation of employment services for people with SUD. Our goals: Reduce overdose deaths and build sustainable, and humane support systems for people impacted by SUDs.

Abt Global is a trusted partner on projects involving people who use drugs and opioids in particular. Over the past 20 years, our multidisciplinary team has helped implement and evaluate interventions to address the root causes of the opioid overdose epidemic and strategies to reduce harm.

Abt researchers working for CDC informed national health policy and science with rigorous data gathering on COVID-19 transmission and vaccine effectiveness.

Washington State’s Integrated Basic Education and Skills Training (I-BEST) program did not produce educational or earnings impacts.